Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Brain Sciences|April 30, 2021
The Prognostic Value of Brain Dysfunction in Critically Ill Patients with and without Sepsis: A Post Hoc Analysis of the ICON AuditIlaria A Crippa, Fabio S Taccone, Xavier Wittebole, et al.
Frontiers in Pharmacology|October 14, 2016
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in RatsFernanda F Peres, Raquel Levin, Mayra A Suiama, et al.
European Journal of Pharmacology|November 28, 2018
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthmaFrancieli Vuolo, Soraia C Abreu, Monique Michels, et al.
European Journal of Pharmacology|January 24, 2012
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptorAlison Ribeiro, Viviane Ferraz-de-Paula, Milena L Pinheiro, et al.
Toxicology and Applied Pharmacology|February 24, 2019
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptorRangel L Silva, Gabriela T Silveira, Carlos W Wanderlei, et al.
Frontiers in Pharmacology|April 4, 2017
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyRaquel A Do Val-da Silva, Jose E Peixoto-Santos, Ludmyla Kandratavicius, et al.
IBRO Neuroscience Reports|July 19, 2024
Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male miceGabriela N Vaz, Flávia C Turcato, Isabel A V Lima, et al.
Autism Research : Official Journal of the International Society for Autism Research|November 26, 2025
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium ValproateKarla C M Costa, Tamires A V Brigante, Pedro H C Lirio, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|August 31, 2025
Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine-model of schizophrenia: sex-dependent effects on positive-like and cognitive impairmentsDaniel B A Prado, Matheus T Rossignoli, Rafael N Ruggiero, et al.
Brain, Behavior, & Immunity - Health|October 11, 2024
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19Rafael R Ferreira, Ronaldo B Martins, Isabela Pires, et al.
Pageof 16